📊 NVST Key Takeaways
Is Envista Holdings Corp (NVST) a Good Investment?
Envista demonstrates solid operational fundamentals with 8.3% revenue growth, strong free cash flow generation ($230.4M, 8.5% margin), and a fortress balance sheet with modest 0.47x leverage. However, profitability is constrained at the net level (1.7% margin) and returns on capital are weak (ROE 1.5%), suggesting operational expenses and debt servicing are limiting shareholder value creation despite healthy gross margins.
Why Buy Envista Holdings Corp Stock? NVST Key Strengths
- Strong free cash flow generation of $230.4M with 8.5% FCF margin, indicating excellent cash conversion despite low net profitability
- Solid revenue growth of 8.3% YoY with robust 54.7% gross margins, demonstrating pricing power and product quality in dental equipment sector
- Conservative capital structure with 0.47x debt-to-equity ratio, 16.8x interest coverage, and strong liquidity (2.38x current ratio) providing financial flexibility
NVST Stock Risks: Envista Holdings Corp Investment Risks
- Extremely low net profit margin of 1.7% and minimal ROE of 1.5% despite healthy gross margins, indicating significant expenses consuming operating income
- High absolute debt level ($1.4B) relative to net income generation ($47M) creates vulnerability to revenue disruptions or margin compression
- Discretionary nature of dental equipment spending makes business sensitive to economic slowdowns and elective procedure deferrals
Key Metrics to Watch
- Net margin expansion and operating leverage improvement despite current 1.7% net margin
- Free cash flow sustainability and debt reduction trajectory relative to operating cash flow
- Organic revenue growth persistence and market share dynamics in dental equipment and supplies sector
Envista Holdings Corp (NVST) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.38x current ratio provides a solid financial cushion.
NVST Profit Margin, ROE & Profitability Analysis
NVST vs Healthcare Sector: How Envista Holdings Corp Compares
How Envista Holdings Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Envista Holdings Corp Stock Overvalued? NVST Valuation Analysis 2026
Based on fundamental analysis, Envista Holdings Corp shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Envista Holdings Corp Balance Sheet: NVST Debt, Cash & Liquidity
NVST Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Envista Holdings Corp's revenue has shown modest growth of 8% over the 5-year period. The most recent EPS of $-0.60 indicates the company is currently unprofitable.
NVST Revenue Growth, EPS Growth & YoY Performance
NVST Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $601.0M | $8.2M | $0.05 |
| Q2 2025 | $633.1M | $18.0M | $0.16 |
| Q1 2025 | $616.9M | $18.0M | $0.10 |
| Q3 2024 | $601.0M | $8.2M | $0.05 |
| Q2 2024 | $633.1M | $23.6M | $0.29 |
| Q1 2024 | $623.6M | $23.6M | $0.14 |
| Q3 2023 | $631.1M | $21.5M | $0.12 |
| Q2 2023 | $645.8M | $47.1M | $0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Envista Holdings Corp Dividends, Buybacks & Capital Allocation
NVST SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Envista Holdings Corp (CIK: 0001757073)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NVST
What is the AI rating for NVST?
Envista Holdings Corp (NVST) has an AI rating of BUY with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NVST's key strengths?
Claude: Strong free cash flow generation of $230.4M with 8.5% FCF margin, indicating excellent cash conversion despite low net profitability. Solid revenue growth of 8.3% YoY with robust 54.7% gross margins, demonstrating pricing power and product quality in dental equipment sector.
What are the risks of investing in NVST?
Claude: Extremely low net profit margin of 1.7% and minimal ROE of 1.5% despite healthy gross margins, indicating significant expenses consuming operating income. High absolute debt level ($1.4B) relative to net income generation ($47M) creates vulnerability to revenue disruptions or margin compression.
What is NVST's revenue and growth?
Envista Holdings Corp reported revenue of $2.7B.
Does NVST pay dividends?
Envista Holdings Corp does not currently pay dividends.
Where can I find NVST SEC filings?
Official SEC filings for Envista Holdings Corp (CIK: 0001757073) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NVST's EPS?
Envista Holdings Corp has a diluted EPS of $0.28.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NVST a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Envista Holdings Corp has a BUY rating with 72% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is NVST stock overvalued or undervalued?
Valuation metrics for NVST: ROE of 1.5% (sector avg: 15%), net margin of 1.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NVST stock in 2026?
Our dual AI analysis gives Envista Holdings Corp a combined BUY rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NVST's free cash flow?
Envista Holdings Corp's operating cash flow is $275.7M, with capital expenditures of $45.3M. FCF margin is 8.5%.
How does NVST compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 1.7% (avg: 12%), ROE 1.5% (avg: 15%), current ratio 2.38 (avg: 2).